Literature DB >> 34156580

A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven.

Rieko Taniguchi1, Hideki Muramatsu2, Yusuke Okuno3, Taro Yoshida1, Manabu Wakamatsu1, Motoharu Hamada1, Chiyoe Shirota4, Wataru Sumida4, Akinari Hinoki5, Takahisa Tainaka4, Yoshimitsu Gotoh6, Toyonori Tsuzuki7, Yukichi Tanaka8, Seiji Kojima1, Hiroo Uchida4, Yoshiyuki Takahashi9.   

Abstract

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is caused by heterozygous germline variants in the fumarate hydratase (FH) gene and is associated with increased susceptibility to cutaneous leiomyomas, uterine leiomyomas, and renal cell carcinoma (RCC). HLRCC-associated RCC usually occurs in the middle age, with the median age being 40-44 years. This report describes a seven-year-old (84-month-old) male who developed a large right kidney tumor with multiple cystic lesions that contained enhanced solid components. There was no evidence of distant metastasis. The male patient underwent right nephrectomy and has been recovering well without metastasis or recurrence. Pathological examination revealed that tumor cells with relatively prominent nucleoli and surrounded by halos, were located in a limited area. Immunohistochemical staining was negative for FH. Whole-exome sequencing identified his germline variant in the FH gene and its loss of heterozygosity in the tumor. At nine years (114 months) of age, the male patient showed no recurrence of the tumor. This was the youngest-onset case of HLRCC-associated RCC to date. This report may affect the starting age for future RCC-surveillance programs for patients with HLRCC.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Cystic renal disease; Fumarate hydratase-deficient renal cell carcinoma; HLRCC; Hereditary leiomyomatosis and renal cell cancer

Mesh:

Substances:

Year:  2021        PMID: 34156580     DOI: 10.1007/s10689-021-00268-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.446


  2 in total

1.  Somatic MECOM mosaicism in a patient with congenital bone marrow failure without a radial abnormality.

Authors:  Tomoo Osumi; Shin-Ichi Tsujimoto; Kazuhiko Nakabayashi; Maki Taniguchi; Ryota Shirai; Masanori Yoshida; Toru Uchiyama; Junko Nagasawa; Susumu Goyama; Takako Yoshioka; Daisuke Tomizawa; Mineo Kurokawa; Yoichi Matsubara; Nobutaka Kiyokawa; Kimikazu Matsumoto; Kenichiro Hata; Motohiro Kato
Journal:  Pediatr Blood Cancer       Date:  2018-01-22       Impact factor: 3.167

2.  Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion?

Authors:  Benjamin T Ristau; Sonal N Kamat; Tatum V Tarin
Journal:  Case Rep Urol       Date:  2015-08-25
  2 in total
  2 in total

1.  A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinoma.

Authors:  Yasuto Yagi; Naoko Abeto; Junichi Shiraishi; Chieko Miyata; Satomi Inoue; Haruka Murakami; Moeko Nakashima; Kokichi Sugano; Mineko Ushiama; Teruhiko Yoshida; Kazuki Yamazawa
Journal:  Hum Genome Var       Date:  2022-01-17

Review 2.  Genodermatoses - Opportunities for Early Detection and Cancer Prevention.

Authors:  Helena Carley; Anjana Kulkarni
Journal:  Curr Genet Med Rep       Date:  2022-10-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.